| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |